Fortschritte der Neurologie · Psychiatrie, Inhaltsverzeichnis Fortschr Neurol Psychiatr 2013; 81(9): 523-538DOI: 10.1055/s-0033-1350145 Fort- und Weiterbildung © Georg Thieme Verlag KG Stuttgart · New York Autoimmune Enzephalitiden Autoimmune Encephalitis F. Leypoldt Artikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 Granerod J, Ambrose HE, Davies NW et al. UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group: Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835-844 2 Noseworthy JH, Lucchinetti C, Rodriguez M et al. Multiple sclerosis. N Engl J Med 2000; 343: 938-952 3 Bien CG, Vincent A, Barnett MH et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012; 135: 1622-1638 4 Hughes EG, Peng X, Gleichman AJ et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-5875 5 Lancaster E, Lai M, Peng X et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. The Lancet Neurology 2010; 9: 67-76 6 Dalmau J, Gleichman AJ, Hughes EG et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098 7 Rosenfeld MR, Dalmau J. Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol 2011; 13: 324-332 8 Brilot F, Dale RC, Selter RC et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 2009; 66: 833-842 9 Giometto B, Grisold W, Vitaliani R et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 2010; 67: 330-335 10 Graus F, Cordon-Cardo C, Posner J. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985; 35: 538-543 11 Prüss H, Dalmau J, Harms L et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010; 75: 1735-1739 12 Dalmau J, Lancaster E, Martinez-Hernandez E et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63-74 13 Irani SR, Bera K, Waters P et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133: 1655-1667 14 Kleinig TJ, Thompson PD, Matar W et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008; 23: 1256-1261 15 Lai M, Huijbers MGM, Lancaster E et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9: 776-785 16 Lancaster E, Huijbers MGM, Bar V et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011; 69: 303-311 17 Irani SR, Michell AW, Lang B et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69: 892-900 18 Lai M, Hughes EG, Peng X et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-434 19 Boronat A, Sabater L, Saiz A et al. GABAB receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 2011; 76: 795-800 20 Pittock SJ, Lucchinetti CF, Parisi JE et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005; 58: 96-107 21 Mas N, Saiz A, Leite MI et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatr 2010; 82: 1399-1401 22 Piotrowicz A, Thümen A, Leite MI et al. A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings. J Neurol 2011; 258: 2268-2270 23 Solimena M, Folli F, Aparisi R et al. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322: 1555-1560 24 Malter MP, Helmstaedter C, Urbach H et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67: 470-478 25 Bertsias GK, Ioannidis JPA, Aringer M et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074-2082 26 Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77: 179-189 27 Leypoldt F, Buchert R, Kleiter I et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatr 2012; 83: 681-686 28 Schmitt SE, Pargeon K, Frechette ES et al. Extreme delta brush: A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79: 1094-1100 29 Psimaras D, Carpentier A, Rossi C. CSF study in paraneoplastic syndromes. J Neurol Neurosurg Psychiatr 2010; 81: 42-45 30 Jarius S, Hoffmann L, Clover L et al. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 2008; 268: 74-77 31 Wandinger K-P, Saschenbrecker S, Stoecker W et al. Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231: 86-91 32 Hadjivassiliou M, Alder SJ, Van Beek EJR et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit. Acta Neurologica Scandinavica 2009; 119: 186-193 33 Titulaer MJ, Soffietti R, Dalmau J et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011; 18: 19-27 34 Graus F, Keime-Guibert F, Reñe R et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-1148 35 Hauser SL, Waubant E, Arnold DL et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358: 676-688 36 Dalakas MC, Koffman B, Fujii M et al. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001; 56: 323-327 37 Srivastava R, Aslam M, Kalluri SR et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012; 367: 115-123
